Mantis XP Sistema de trombectomía para fístula
A alta potencia Dispositivo de trombectomía mecánica para oclusiones arteriales o venosas profundas, que permite un mayor alcance y una extracción robusta del coágulo en anatomías complejas.
En Mantis XP es un pharmacomechanical thrombectomy system specifically engineered for dialysis native AV fistulae. Featuring a rotacional catheter design and sinusoidal wave geometry, Mantis XP enables rapid y efficient clot disruption, infusion, and evacuation in a single pass—helping to restore patency while minimizing potential vessel trauma in end-stage renal disease (ESRD) patients requiring continuous dialysis access.
Rotational Thrombectomy Mechanism
- Sinusoidal Wave Shape: The unique sinusoidal wire design translates rotational energy into targeted clot fragmentation, limiting stress on native fistula walls.
- Pharmacomechanical Combination: Simultaneously administers lytic agents (if required) via the infusion zone, accelerating clot dissolution and removal.
Extended Infusion Zone
- 10 cm from Distal Tip: Delivers thrombolytic or flushing solutions directly to the lesion area, optimizing pharmacologic contact with the clot.
- Efficient Local Drug Delivery: Improves clot breakdown while minimizing systemic agent usage.
Variable Catheter Length & Profile
- Longitudes: 30 cm, 45 cm, 90 cm, 110 cm provide flexibility for short or extended vascular access routes—particularly relevant for complex fistula anatomies.
- Profiles: 5.0F–7.0F outer diameters suit different vessel sizes, ensuring robust torque transmission and navigability.
Nitinol & PA/PEBAX Construction
- Nitinol Core: Maintains shape integrity and provides kink resistance, critical in tortuous AV fistula segments.
- PTFE Inner Layer: Minimizes friction with guidewires and helps protect vessel surfaces during repeated manipulations.
Radiopacity & Visibility
- Braided Shaft: Allows real-time tracking under fluoroscopy, visible from the distal tip to the proximal segment.
- 15 cm Active Zone: Clear identification ensures accurate lesion coverage and improved operator confidence.
- Sinusoidal Wave Shape: The unique sinusoidal wire design translates rotational energy into targeted clot fragmentation, limiting stress on native fistula walls.
- Pharmacomechanical Combination: Simultaneously administers lytic agents (if required) via the infusion zone, accelerating clot dissolution and removal.
- 10 cm from Distal Tip: Delivers thrombolytic or flushing solutions directly to the lesion area, optimizing pharmacologic contact with the clot.
- Efficient Local Drug Delivery: Improves clot breakdown while minimizing systemic agent usage.
- Longitudes: 30 cm, 45 cm, 90 cm, 110 cm provide flexibility for short or extended vascular access routes—particularly relevant for complex fistula anatomies.
- Profiles: 5.0F–7.0F outer diameters suit different vessel sizes, ensuring robust torque transmission and navigability.
- Nitinol Core: Maintains shape integrity and provides kink resistance, critical in tortuous AV fistula segments.
- PTFE Inner Layer: Minimizes friction with guidewires and helps protect vessel surfaces during repeated manipulations.
- Braided Shaft: Allows real-time tracking under fluoroscopy, visible from the distal tip to the proximal segment.
- 15 cm Active Zone: Clear identification ensures accurate lesion coverage and improved operator confidence.
Especificaciones del producto
Especificación | Detalle / Valor |
Nombre del producto | Mantis XP Thrombectomy System |
Uso previsto | High-powered mechanical thrombectomy in venous or arterial occlusions, removing large or organized clot |
Diseño del catéter | Rotational shaft with extended reach (“XP”), integrated aspiration lumen or side port |
Material | Stainless steel or nitinol core, polymer outer sheath |
Velocidad de rotación | ~50k–120k rpm (verify final) |
Diámetro exterior (F) | ~6–8F (depending on model) |
Longitud de trabajo | ~80–120 cm (varies by product code) |
Compatibilidad de guías | Typically 0.035” |
Esterilidad | Estéril, un solo uso |
Vida útil | ~2-3 años si se almacena a 15-25 °C en envase cerrado |
Indicaciones clínicas | Large clot burdens in major peripheral veins/arteries, deep venous thrombosis (DVT), acute limb ischemia |
Contraindicaciones | Extremely tortuous vessels, heavily calcified segments, or known sensitivity to device materials |
Matriz de pedidos y tamaños
Diámetro exterior (F) | Longitud de trabajo (cm) | Configuración de la punta | Código del producto | Notas |
6F | 80 | Standard Rotational Tip | MNT-XP-6F-80-SR | Smaller OD for moderate clot loads |
6F | 100 | Leaf Tip | MNT-XP-6F-100-LF | Intermediate length, specialized tip for large clot |
7F | 80 | Standard Rotational Tip | MNT-XP-7F-80-SR | Larger OD for heavier clot burden |
7F | 120 | Leaf Tip | MNT-XP-7F-120-LF | Extended shaft + specialized tip for extensive occlusions |
8F | 100 | Standard Rotational Tip | MNT-XP-8F-100-SR | Max diameter & high rotational power for dense clots |
8F | 120 | Leaf Tip | MNT-XP-8F-120-LF | Extended length + leaf tip for severe multi-segment thrombosis |
Productos relacionados
-
Nexus Cánula venosa y arterial
Leer másMultiusos venoso y arterial cánulas de soporte circulación extracorpórea durante el bypass cardiopulmonar o la ECMO, garantizando una óptima caudales y hemocompatibilidad.
-
LaserBLOCK Sistema láser para varices
Leer másEn endovenoso set de terapia láser para varices venas, aprovechamiento objetivo energía láser para sellar térmicamente las venas incompetentes, lo que permite una rápida reincorporación a la actividad diaria.
-
Venablock ™ Sistema de cierre de venas para el tratamiento de varices
Leer másVenablock ™ Sistema de cierre de venas para el tratamiento de varices; A a base de cianoacrilato sistema de cierre de venas para superficial incompetencia venosa, parto no térmico oclusión con anestesia local mínima y rápido recuperación tras el procedimiento.
-
Extender Catéter balón PTCA liberador de fármaco Paclitaxel
Leer másA recubierto de paclitaxel catéter coronario de balón dirigido a reducir la reestenosis durante la angioplastia coronaria transluminal percutánea (ACTP), garantizando la administración eficaz del fármaco a la pared vascular.